1-minute read
Surgical site infections (SSIs) remain a major concern in healthcare, affecting a significant number of patients and driving up costs.1-3 These infections don’t just impact patient recovery—they lead to longer hospital stays, higher rates of complications, and an enormous financial burden on the healthcare system.1-3 In the U.S. alone, SSIs account for billions in annual expenses.4.5 With healthcare moving toward bundled payments and performance-based reimbursements, preventing these infections has become even more critical. SSIs are now the leading cause of unplanned hospital readmissions6 and reducing them could make a substantial difference in both patient outcomes and hospital costs.
Reducing the risk of SSIs requires a comprehensive approach that targets the most common sources of bacterial colonization: the nose, mouth, and skin. While strategies like nasal, skin, and oral antisepsis are critical, compliance and education remain key challenges. We need standardized, evidence-based protocols and a multidisciplinary effort to make real progress. By working together—surgeons, nurses, infection prevention teams, and patients—we can reduce the risk of SSIs and improve surgical outcomes.
Tyler Smith, D.O.
Surgical site infection is a primary threat to your surgical patients. SSIs are, in most cases, preventable when the patient and hospital staff members adhere to proper prevention practices.1 Our cloths are clinically proven to address bacteria on the skin and can standardize your pre-op approach for maximum efficiency and enhanced compliance.
Learn moreTyler Smith, D.O. is a paid consultant of Stryker. The data included in this presentation was collected by the author of this presentation. The opinions expressed are those of Tyler Smith, D.O. and are not necessarily those of Stryker. Individual results may vary.
*equivalent to 500mg Chlorhexidine Gluconate per cloth
References:
1. Seidelman JL, Mantyh CR, Anderson DJ, (2023). Surgical Site Infection Prevention: A Review. JAMA, 329(3), 244.
2. Kang M, Andrew ME, Farishta A, et al., (2023). Best Practices and a Business Case for Surgical Site Infection Prevention. AORN Journal, 117(5), 277–290.
3. Piednoir E, Robert-Yap J, Baillet P, et al., (2021). The Socioeconomic Impact of Surgical Site Infections. Frontiers in Public Health, 9, 712461.
4. Anderson DJ, Podgorny K, Berríos-Torres SI, et al., (2014). Strategies to Prevent Surgical Site Infections in Acute Care Hospitals: 2014 Update. Infection Control & Hospital Epidemiology, 35(6), 605–627.
5. Zimlichman E, Henderson D, Tamir O, et al., (2013). Health Care–Associated Infections: A Meta-analysis of Costs and Financial Impact on the US Health Care System. JAMA Internal Medicine, 173(22), 2039.
6. Merkow RP, Ju MH, Chung JW, Hall et al., (2015). Underlying Reasons Associated With Hospital Readmission Following Surgery in the United States. JAMA, 313(5), 483.
SAGE-SC-COMM-1279087_REV-0_en_us